Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Bases de datos
Asunto principal
Tipo del documento
Asunto de la revista
Intervalo de año de publicación
1.
J Drugs Dermatol ; 23(3): SF395747s6-SF395747s11, 2024 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-38443136

RESUMEN

Atopic Dermatitis (AD) epidemiologic studies report a higher incidence and prevalence among populations with skin of color (SOC). Additionally, differences in AD underlying gene mutations and skin morphology are observed to lead to frequent and prominent xerosis, pruritus, and pigmentary sequelae in patients of color. However, populations with SOC are underrepresented in dermatology clinical trials, including AD. This article reviews the nuances in AD epidemiology, clinical presentation, and impact on quality-of-life among populations with SOC, plus highlight the role of skincare in AD management. J Drugs Dermatol. 2024;23:3(Suppl 2):s6-11.


Asunto(s)
Dermatitis Atópica , Humanos , Dermatitis Atópica/diagnóstico , Dermatitis Atópica/epidemiología , Dermatitis Atópica/terapia , Trastornos de la Pigmentación , Prurito , Calidad de Vida , Piel , Minorías Étnicas y Raciales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA